Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/3/25 21:53 | 4/1/25 | BEAM | Health | BioPrd | Biological Products, (No Diag | Bellon Christine | MA | O | GC | 3 | S.d | -516 | 20.11 | 0 | -26 | 117 | D | |||||||||||||||
4/3/25 21:52 | 4/1/25 | BEAM | Health | BioPrd | Biological Products, (No Diag | Evans John M. | MA | DO | CEO | 2 | S.ad | -583 | 9.61 | 0 | -61 | 1,089 | D | |||||||||||||||
4/3/25 21:51 | 4/1/25 | BEAM | Health | BioPrd | Biological Products, (No Diag | Ciaramella Giuseppe | MA | O | P | 1 | S | -136 | 18.35 | 0 | -7 | 190 | D | |||||||||||||||
4/3/25 21:50 | 4/1/25 | BEAM | Health | BioPrd | Biological Products, (No Diag | Cavanagh Bethany J | MA | O | SVP,Fina | 2 | S | -275 | 29.60 | 0 | -9 | 45 | D | |||||||||||||||
4/3/25 21:50 | 4/1/25 | BEAM | Health | BioPrd | Biological Products, (No Diag | Simon Amy | MA | O | Chief Me | 1 | S.m | -548 | 17.92 | 0 | -31 | 66 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |